PI Pharma Insight

BNF presentation directory

Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.

Reset

Active filters

  • Chemical substance: Topiramate
Presentation Product Chemical substance Chapter Items dispensed
Topiramate 150mg/5ml oral liquid
040801050AABSBS
Topiramate Topiramate Central Nervous System No data available
Topiramate 15mg/5ml oral liquid
040801050AABVBV
Topiramate Topiramate Central Nervous System No data available
Topiramate 16mg/5ml oral liquid
040801050AABTBT
Topiramate Topiramate Central Nervous System No data available
Topiramate 200mg/5ml oral liquid
040801050AABABA
Topiramate Topiramate Central Nervous System No data available
Topiramate 20mg/5ml oral liquid
040801050AABDBD
Topiramate Topiramate Central Nervous System No data available
Topiramate 250mg/5ml oral suspension
040801050AABZBZ
Topiramate Topiramate Central Nervous System No data available
Topiramate 25mg/5ml oral solution
040801050AACECE
Topiramate Topiramate Central Nervous System No data available
Topiramate 30mg/5ml oral liquid
040801050AABLBL
Topiramate Topiramate Central Nervous System No data available
Topiramate 35mg/5ml oral liquid
040801050AABRBR
Topiramate Topiramate Central Nervous System No data available
Topiramate 5mg/5ml oral liquid
040801050AABIBI
Topiramate Topiramate Central Nervous System No data available
Topiramate 6.25mg/5ml oral liquid
040801050AABHBH
Topiramate Topiramate Central Nervous System No data available
Topiramate 62.5mg/5ml oral suspension
040801050AACDCD
Topiramate Topiramate Central Nervous System No data available
Topiramate 67.5mg/5ml oral liquid
040801050AABUBU
Topiramate Topiramate Central Nervous System No data available
Topiramate 75mg/5ml oral liquid
040801050AAASAS
Topiramate Topiramate Central Nervous System No data available
Topiramate 8mg/5ml oral suspension
040801050AACFCF
Topiramate Topiramate Central Nervous System No data available

Why monitor BNF codes?

Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.

Track cost pressure

Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.

Understand demand drivers

Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.